SCHEMBL30636778

SCHEMBL30636778

CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@@H](C)O)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ GLP1R P43220 12/20 0.55
▸ OPRM1 P35372 4/20 0.54
▸ OPRD1 P41143 4/20 0.54
▸ OPRK1 P41145 3/20 0.53
▸ SCTR P47872 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31256793 0.97 OPRM1 (0.55) GLP1ROPRM1OPRD1OPRK1SCTR
SCHEMBL30407947 0.96 OPRM1 (0.55) GLP1ROPRM1OPRD1OPRK1
SCHEMBL30299020 0.92 GLP1R (0.58) GLP1ROPRM1OPRD1OPRK1
SCHEMBL31256795 0.92 OPRM1 (0.57) GLP1ROPRM1OPRD1OPRK1SCTR
SCHEMBL31030934 0.91 GLP1R (0.57) GLP1ROPRM1OPRD1OPRK1
SCHEMBL30918524 0.91 GLP1R (0.58) GLP1ROPRM1OPRD1OPRK1
SCHEMBL30169866 0.90 GLP1R (0.50) GLP1ROPRM1OPRD1OPRK1
SCHEMBL30368416 0.90 OPRM1 (0.56) GLP1ROPRM1OPRD1OPRK1
SCHEMBL31258952 0.89 OPRD1 (0.57) GLP1ROPRM1OPRD1OPRK1SCTR
SCHEMBL31062669 0.89 GLP1R (0.65) GLP1ROPRM1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4434536-A1 STAPLED PEPTIDE AND USE THEREOF Medshine Discovery Inc. (CN) 2024-09-25 — — EP claimed
WO-2025264785-A1 CHEMICALLY MODIFIED PEPTIDES AND USE THEREOF NEUROCRINE BIOSCIENCES, INC. (US) 2025-12-26 — — WO disclosed
WO-2025264809-A1 CHEMICALLY MODIFIED PEPTIDES AND USE THEREOF NEUROCRINE BIOSCIENCES, INC. (US) 2025-12-26 — — WO disclosed
EP-4434536-A1 STAPLED PEPTIDE AND USE THEREOF Medshine Discovery Inc. (CN) 2024-09-25 — — EP disclosed
CN-117024528-B Preparation method of Retatrutide 杭州信海医药科技有限公司 2024-03-22 — — CN disclosed
CN-117024528-A Preparation method of Retatrutide 杭州信海医药科技有限公司 2023-11-10 — — CN disclosed
Send feedback